ARDT 8-K: Secondary offering

Filed with the SEC on · accession 0001104659-26-130121

ARDT filed a 8-K (current report) with the SEC on Nov 19, 2026. Selling stockholders EGI-AM Investments and ALH Holdings (a Ventas subsidiary) sold 8,000,000 shares of Ardent Health common stock at $14.50 per share in a secondary offering, with the company receiving no proceeds. The stock moved +0.7% by the first close after the filing.

Summary of the filing

Selling stockholders EGI-AM Investments and ALH Holdings (a Ventas subsidiary) sold 8,000,000 shares of Ardent Health common stock at $14.50 per share in a secondary offering, with the company receiving no proceeds. Concurrently, Ardent repurchased 1,500,000 of those shares from the underwriters at $13.7025 per share using existing cash.

Key details

Shares sold by selling stockholders in secondary offeringshares 8.0M
Public offering price per share$15
Gross value of secondary offering$116.0M
Additional shares subject to 30-day underwriter optionshares 1.2M
Shares repurchased by company from underwritersshares 1.5M
Concurrent share repurchase price per share$14
Total value of concurrent share repurchase$20.6M
Remaining repurchase authorization under existing program$48.0M
Issuer/registrant; conducted concurrent share repurchaseArdent Health, Inc.
Selling stockholder; affiliate of equity group investmentsEGI-AM Investments, L.L.C.
Selling stockholder; subsidiary of ventas, inc.ALH Holdings, LLC
Underwriter representativeJ.P. Morgan Securities LLC
Underwriter representativeBarclays Capital Inc.
Executive vice president & general counselStephen C. Petrovich

How ARDT stock reacted

Close before

$14.40

Nov 18, 2026

First close after

+0.69%

$14.50

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ARDT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ARDT?

Click here

Frequently asked questions

What did ARDT file with the SEC on Nov 19, 2026?

ARDT filed a 8-K (Secondary offering). Selling stockholders EGI-AM Investments and ALH Holdings (a Ventas subsidiary) sold 8,000,000 shares of Ardent Health common stock at $14.50 per share in a secondary offering, with the company receiving no proceeds. Concurrently, Ardent repurchased 1,500,000 of those shares from the underwriters at $13.7025 per share using existing cash.

What does a secondary offering mean for ARDT stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did ARDT stock react to this filing?

ARDT closed at $14.40 before the filing and $14.50 on Nov 19, 2026 (+0.69%).

Other ARDT SEC filings

Get alerts when ARDT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days